HollisterStier, GeneraMedix Enter Manufacturing Pact

HollisterStier Contract Manufacturing has signed a manufacturing contract with GeneraMedix, Inc. to develop a process for compounding and lyophilizing multiple generic drug products. GeneraMedix plans to use HollisterStier’s project management system to meet timelines and project specifications. Further details of the agreement were not disclosed.

Anthony Bonanzino Ph.D., president and chief executive officer of HollisterStier said, “Establishing this new arrangement with GeneraMedix is further evidence of HollisterStier’s substantial technical competency. Merging the core competencies of each organization assures a rapid market introduction to meet this important patient need.”

Ronald F. Quadrel, president and chief executive officer of GeneraMedix said, “This new agreement with HollisterStier Contract Manufacturing is another step in the development and buildup of our generic injectable product portfolio. We are very pleased to be working together with HollisterStier on these new products. We believe that HollisterStier has the team, the experience and the infrastructure to ensure the successful development and commercial supply of these products.”